Dupilumab treatment is not associated with changes in lymphoma risk in atopic dermatitis and other type 2 inflammatory diseases: data from a large-scale retrospective cohort study
- Khalaf Kridin
- , Katja Bieber
- , Henning Olbrich
- , Dagmar von Bubnoff
- , Gema Hernandez
- , Henner Zirpel
- , Nikolas von Bubnoff
- , Diamant Thaçi
- , Ralf J. Ludwig
Research output: Contribution to journal › Article › peer-review